Recent Advances in Herbal Medicines – An Updated Review

Authors

  • Dhritiman Roy Deparment of Pharmaceutical Technology,Calcutta Institute of Pharmaceutical Technology and  AHS,Banitabla, Uluberia, Howrah, West Bengal
  • Arindam Chakraborty School of Pharmacy, Seacom Skills University, Bolpur, Birbhum, West Bengal, India
  • Payel Mukherjee Department of Pharmaceutics, M.R. College of Pharmaceutical Sciences and Research, Bira, Balisha, North 24 Parganas, West Bengal, India
  • Balaram Ghosh Department of Pharmaceutics,Calcutta Institute of Pharmaceutical Technology And AHS, Banitabla, Uluberia, Howrah, West Bengal, India
  • Manas Chakraborty Head of The Department, Department of Pharmaceutical Biotechnology, Calcutta Institute of Pharmaceutical Technology And AHS, Banitabla, Uluberia, Howrah, West Bengal, India

DOI:

https://doi.org/10.22270/ajprd.v10i1.1089

Keywords:

Herbal drugs, Pharmacovigilance, Traditional healthcare system, Standardization,Drug interactions, Adverse drug reactions.

Abstract

Nowadays peoples throughout the world have been attracting towards the herbal medicines.  Worldwide favour the traditional healthcare system, so day-by-day uses of herbal remedies to cure diseases is increase instead of alternative medicines. Herbal drugs have an ability to maintain health and to treat various diseases therefore herbal drugs have been used since very earlier days. To fulfil the public requirement many companies have been using herbal drug technology for converting botanical materials into medicines, where standardization, quality control, modern scientific techniques and traditional knowledge are very necessary. This review focuses on recent trends in Herbal drugs and main motto is to explain the therapeutic effectiveness of various herbal drugs, adverse drug reactions, drug interactions, standardization and stability testing of herbal medicines, pharmacovigilance and regulatory status of herbal medicines.

 

Downloads

Download data is not yet available.

Author Biographies

Dhritiman Roy, Deparment of Pharmaceutical Technology,Calcutta Institute of Pharmaceutical Technology and  AHS,Banitabla, Uluberia, Howrah, West Bengal

Deparment of Pharmaceutical Technology,Calcutta Institute of Pharmaceutical Technology and  AHS,Banitabla, Uluberia, Howrah, West Bengal

Arindam Chakraborty, School of Pharmacy, Seacom Skills University, Bolpur, Birbhum, West Bengal, India

School of Pharmacy, Seacom Skills University, Bolpur, Birbhum, West Bengal, India

Payel Mukherjee, Department of Pharmaceutics, M.R. College of Pharmaceutical Sciences and Research, Bira, Balisha, North 24 Parganas, West Bengal, India

Department of Pharmaceutics, M.R. College of Pharmaceutical Sciences and Research, Bira, Balisha, North 24 Parganas, West Bengal, India

Balaram Ghosh, Department of Pharmaceutics,Calcutta Institute of Pharmaceutical Technology And AHS, Banitabla, Uluberia, Howrah, West Bengal, India

Department of Pharmaceutics,Calcutta Institute of Pharmaceutical Technology And AHS,Banitabla,Uluberia, Howrah, West Bengal, India

Manas Chakraborty, Head of The Department, Department of Pharmaceutical Biotechnology, Calcutta Institute of Pharmaceutical Technology And AHS, Banitabla, Uluberia, Howrah, West Bengal, India

Head of The Department, Department of Pharmaceutical Biotechnology, Calcutta Institute of Pharmaceutical Technology And AHS,Banitabla, Uluberia, Howrah, West Bengal,India

References

1. Firenzuoli F, Gori L, Crupi A, Neri D. Flavonoids: risks or therapeutic opportunities? RecentiProg Med 2004; 95:345–51.
2. Chiappelli F, Prolo P, Rosenblum M, Edgerton M, Cajulis OS. Evidence-based research in complementary and alternative medicine II: the process of evidence-based research. Evid Based Complement Alternat Med 2006; 3:3–12.
3. Barnes LL. The psychologizing of Chinese healing practices in the United States. Cult Med Psychiatry 1998; 22:413–43.
4. Cardini F, Wade C, Regalia AL, Gui S, Li W, Raschetti R, Kronenberg F. Clinical research in traditional medicine: priorities and methods. ComplTher Med 2006; 14:282–87.
5. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006; 144:364–67.
6. Winslow L, Kroll, DJ, Herbs as Medicines, Archives of Internal Medicine.1998: 2192-9.
7. Gossell M, Simon OR, West ME .The past and the present use of plants for medicines. West Ind Med J. 2006; 55:217.
8. De-Smet, PGAM. The role of plant derived drugs and herbal medicines in healthcare drugs.5th ed. Edinburgh. 1997; 801-40.
9. WHO technical report series. Guidelines for the Assessment of Herbal Medicines. 1996; 178-84.
10. Abhishek K, Ashutosh M and Sinha BN .Herbal drugs- present status and efforts to promote and regulate cultivation. The Pharm Rev.2006; 6:73-7.
11. Coleman LM, Fowler LL, Williams ME, Use of unproven therapies by people with alzheimer’s disease, Journal of the American Geriatrics Society,1995 ; 43:747-750.
12. Sutherland LR, Verhoef MJ, Why do patients seek a second opinion or alternative medicine, Clinical Gastroenterology,1994; 19:194-197.
13. Catherine C, Crone MD, Thomas N, Wise MD, Use of herbal medicines among consultation-liaison populations, The Academy of Psychosomatic Medicine, 1998; 39(1):3-13.
14. Sehgal A, Herbal medicines-harmless or harmful, Anesthesia, 2003; 57:947-948.
15. Bigoniya, P, “Pharmacovigilance ofherbal medicines: current status and futurestrategies”, The Pharma Review, 5, 77-88.
16. Chan, TYK (1997), “Monitoring the safetyof herbal medicines”, Drug Safety, 1997; 17:209-215.
17. Sukhdev, S; Arun, N and Kalia, AN,“Patentability of herbal products: Areview”, The Pharma Review,2008; 4:118-124.
18. Raskin, L et al., “Plants and humanhealth in the twenty first century”, Trendsin Biotechnology, 2002;20 (12):522-531.
19. Calixto, JB, “Efficacy, safety,quality control, marketing, and regulatoryguidelines for herbal medicines”, BrazilianJournal of Medical and Biological Research,2008; 33:179-189.
20. Verma, S and Singh, SP, “Currentand future status of herbal medicines”,Veterinary World,2008; 1(11):347-350.
21. Alam, S et al., “Role of herbals indrug delivery system”, The PharmaReview, 2007; 6:106-107.
22. Nahin LR, Straus ES. Research into complementary and alternative medicine: problems and potential. Br Med J 2001; 322:161–4.
23. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156:5–10.
24. Roland M, Torgeson DJ. What are pragmatic trials? BMJ 1998;316:285.
25. Allen JJB, Schnyer RH, Hitt SK. The efficacy of acupuncture in the treatment of major depression in women. PsycholSci 1989:397–401.
26. Medical Research Council (MRC). A framework for development and evaluation of RCTs for complex interventions to improve health. April 2000. Available at: http://www.mrc.ac.uk/Utilities/ Documentrecord/index.htm?d=MRC003372htt (accessed on 23rd August 2007).
27. Chavan P, Joshi K, Patwardhan B. DNA microarrays in herbal drug research. Evid. Based Complement. Alternat. Med 2006; 3:447–57.
28. Dipankar G, Laddha KS, Harbal safety and GMP: The most debatable argument in the present scenario, The Pharma Review, 2006; 2:25-29.
29. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ, Leads from Indian medicinal plants with hypoglycemic potentials, Journal of Ethnopharmacology, 106, 2006; 1-28.
30. Poul BN, Patil SS, Kadam CS, Mhaske AR, SomnatheND, Herbal drug with antidiabetic activity, The Pharma Review, 2007; 2:69-72.

Published

2022-02-15

How to Cite

Roy, D., Chakraborty, A., Mukherjee, P., Ghosh, B., & Chakraborty, M. (2022). Recent Advances in Herbal Medicines – An Updated Review. Asian Journal of Pharmaceutical Research and Development, 10(1), 45–48. https://doi.org/10.22270/ajprd.v10i1.1089